These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 4717322)

  • 1. The effect of alprenolol on hemodynamics in angina pectoris.
    Cullhed I
    Acta Med Scand; 1973 May; 193(5):411-8. PubMed ID: 4717322
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of cedilanid-D and alprenolol in angina pectoris.
    Ekelund LG; Johnsson G; Melcher A; Orö L
    Eur J Clin Pharmacol; 1973 Aug; 6(2):113-8. PubMed ID: 4769694
    [No Abstract]   [Full Text] [Related]  

  • 3. Alprenolol alone and in conjunction with pentanitrol in angina pectoris. A double-blind study with exercise tests.
    Hansen PF; Rasmussen PA; Nyberg G
    Acta Med Scand; 1973 May; 193(5):419-24. PubMed ID: 4197873
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of alprenolol on central hemodynamics and exercise tolerance in patients with angina pectoris.
    Jonsson B; Olsson AG; Orö L
    Cardiology; 1973; 58(3):152-61. PubMed ID: 4149331
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of beta-adrenergic blockade with alprenolol on ST-segment depression and circulatory dynamics during exercise in patients with effort angina.
    Bailey IK; Anderson SD; Rozea PJ; Bernstein L; Nyberg G; Korner PI
    Am Heart J; 1976 Oct; 92(4):416-26. PubMed ID: 961582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris.
    Aström H; Vallin H
    Br Heart J; 1974 Dec; 36(12):1194-1200. PubMed ID: 4155316
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical, electrocardiographic, and haemodynamic effects of digitalis (ouabain) in angina pectoris.
    Sharma B; Majid PA; Meeran MK; Whitaker W; Taylor SH
    Br Heart J; 1972 Jun; 34(6):631-7. PubMed ID: 4402698
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemodynamic changes at rest and during exercise in long-term beta-blocker therapy of essential hypertension.
    Lund-Johansen P
    Acta Med Scand; 1974; 195(1-2):117-21. PubMed ID: 4817079
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute effect of nitroglycerin on haemodynamics of angina pectoris.
    Arborelius M; Lecerof H; Malm A; Malmborg RO
    Br Heart J; 1968 May; 30(3):407-11. PubMed ID: 4967901
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of beta-adrenergic blockade (propranolol) on left ventricular hemodynamics and the electrocardiogram during exercise-induced angina pectoris.
    Dwyer EM; Wiener L; Cox JW
    Circulation; 1968 Aug; 38(2):250-60. PubMed ID: 5666841
    [No Abstract]   [Full Text] [Related]  

  • 11. Central haemodynamic effects in man of intravenous d-alprenolol during rest and exercise.
    Ekelund LG; Melcher A; Orö L
    Eur J Clin Pharmacol; 1971 Sep; 3(4):198-203. PubMed ID: 5151303
    [No Abstract]   [Full Text] [Related]  

  • 12. Haemodynamic effects of angina pectoris, and of nitroglycerin in normal and anginal subjects.
    Hoeschen RJ; Bousvaros GA; Klassen GA; Fam WM; McGregor M
    Br Heart J; 1966 Mar; 28(2):221-30. PubMed ID: 5006472
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of single doses of alprenolol and two cardioselective beta-blockers (H 87-07 and H 93-26) on exercise-induced angina pectoris.
    Adolfsson L; Areskog NH; Furberg C; Johnsson G
    Eur J Clin Pharmacol; 1974; 7(2):111-8. PubMed ID: 4152864
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta-adrenergic receptor blocking drugs in angina pectoris.
    Prichard BN
    Drugs; 1974; 7(1):55-84. PubMed ID: 4151695
    [No Abstract]   [Full Text] [Related]  

  • 15. Haemodynamic effects of beta-adrenergic blockade.
    Aström H
    Br Heart J; 1968 Jan; 30(1):44-9. PubMed ID: 5637556
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemodynamic effects of beta-receptor blocking agents and digitalis in ischaemic coronary heart disease with angina pectoris.
    Dunér H; Pernow B
    Acta Med Scand; 1973 Dec; 194(6):517-23. PubMed ID: 4589794
    [No Abstract]   [Full Text] [Related]  

  • 17. Circulatory responses to beta adrenergic blockade with alprenolol. Studies in patients with chronic heart disease.
    Kerber RE; Goldman RH; Alderman EL; Harrison DC
    Am J Cardiol; 1972 Jan; 29(1):26-32. PubMed ID: 4399889
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of smoking cigarettes on cardiovascular hemodynamics.
    Aronow WS; Goldsmith JR; Kern JC; Cassidy J; Nelson WH; Johnson LL; Adams W
    Arch Environ Health; 1974 Jun; 28(6):330-2. PubMed ID: 4829088
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of angina pectoris. Therapeutic methods and physiologic mechanisms.
    Amsterdam EA; Hughes JL; Miller RR; Massumi RA; Zelis R; Mason DT
    Adv Cardiol; 1974; 11(00):175-90. PubMed ID: 4213235
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of alprenolol on hemodynamic and metabolic responses to prolonged exercise in subjects with hypertension.
    Frisk-Holmberg M; Jorfeldt L; Juhlin-Dannfeldt A
    Clin Pharmacol Ther; 1977 Jun; 21(6):675-84. PubMed ID: 324693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.